Indeed, intra-cerebellar or intraventricular administration of IgGs from patients with GAD-Ab and SPS or cerebellar ataxia blocks neuronal functions and impairs synaptic regulation [33, 35]. The gene discussed is GAD1; the disease is cerebellar ataxia.